Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rin Yamaguchi

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Modern Rheumatology Case Reports|October 22, 2020
A case of acute diffuse large B cell lymphoma in an anti-human T-cell leukaemia virus type 1-positive rheumatoid arthritis patient treated with methotrexate, who diedNaomi Yoshida, Gen Sugiyama, Suzuna Sugi, et al.
Japanese Journal of Radiology|August 29, 2009
Mastopathic-type fibroadenoma and ductal adenoma of the breast with false-positive fluorodeoxyglucose positron emission tomographyRin Yamaguchi, Yasuhiko Futamata, Fumihiro Yoshimura, et al.
Breast Cancer Research and Treatment|November 26, 2013
Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancersJulia Y S Tsang, Suen-Wah Hui, Yun-Bi Ni, et al.
Pathology International|December 11, 2007
Clinicopathological study of invasive ductal carcinoma with large central acellular zone: special reference to magnetic resonance imaging findingsRin Yamaguchi, Hidemi Furusawa, Hiroshi Nakahara, et al.
Breast Cancer Research and Treatment|August 10, 2020
Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinomaMomoko Akashi, Rin Yamaguchi, Hironori Kusano, et al.
Cancer Medicine|April 11, 2016
CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situMichi Morita, Rin Yamaguchi, Maki Tanaka, et al.
Human Pathology|April 21, 2012
Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancerRin Yamaguchi, Maki Tanaka, Ayako Yano, et al.
Pathology International|January 9, 2010
Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imagingRin Yamaguchi, Maki Tanaka, Toshiro Yokoyama, et al.
Oncotarget|January 21, 2017
The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancerHitomi Mori, Makoto Kubo, Rin Yamaguchi, et al.
Diagnostic Pathology|May 22, 2012
Evaluation of inadequate, indeterminate, false-negative and false-positive cases in cytological examination for breast cancer according to histological typeRin Yamaguchi, Shin-ichi Tsuchiya, Takashi Koshikawa, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Modern Rheumatology Case Reports|October 22, 2020
A case of acute diffuse large B cell lymphoma in an anti-human T-cell leukaemia virus type 1-positive rheumatoid arthritis patient treated with methotrexate, who diedNaomi Yoshida, Gen Sugiyama, Suzuna Sugi, et al.
Japanese Journal of Radiology|August 29, 2009
Mastopathic-type fibroadenoma and ductal adenoma of the breast with false-positive fluorodeoxyglucose positron emission tomographyRin Yamaguchi, Yasuhiko Futamata, Fumihiro Yoshimura, et al.
Breast Cancer Research and Treatment|November 26, 2013
Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancersJulia Y S Tsang, Suen-Wah Hui, Yun-Bi Ni, et al.
Pathology International|December 11, 2007
Clinicopathological study of invasive ductal carcinoma with large central acellular zone: special reference to magnetic resonance imaging findingsRin Yamaguchi, Hidemi Furusawa, Hiroshi Nakahara, et al.
Breast Cancer Research and Treatment|August 10, 2020
Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinomaMomoko Akashi, Rin Yamaguchi, Hironori Kusano, et al.
Cancer Medicine|April 11, 2016
CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situMichi Morita, Rin Yamaguchi, Maki Tanaka, et al.
Human Pathology|April 21, 2012
Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancerRin Yamaguchi, Maki Tanaka, Ayako Yano, et al.
Pathology International|January 9, 2010
Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imagingRin Yamaguchi, Maki Tanaka, Toshiro Yokoyama, et al.
Oncotarget|January 21, 2017
The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancerHitomi Mori, Makoto Kubo, Rin Yamaguchi, et al.
Diagnostic Pathology|May 22, 2012
Evaluation of inadequate, indeterminate, false-negative and false-positive cases in cytological examination for breast cancer according to histological typeRin Yamaguchi, Shin-ichi Tsuchiya, Takashi Koshikawa, et al.
Pageof 11